RxDoctor Payments Data
★ My doctorsLook up a doctor →

Kourtne Roberts

Psychiatry · Victoria, TXNPI 1851702997

Payments from drug & device makers

$10,114in general payments, 2019–2025

Across 260 payments — averaging $38.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$3K
  • Axsome Therapeutics, Inc.$2K
  • Alkermes, Inc.$898
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$785
  • AbbVie$765
  • Otsuka America Pharmaceutical, Inc.$673
  • plus $2K from 12 others

What the payments were for

  • Consulting fees$3,55035%
  • Travel & lodging$2863%
  • Food & beverage$6,07460%
  • Education$2042%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teva Pharmaceuticals USA, Inc.34$3,005
Axsome Therapeutics, Inc.13$2,216
Alkermes, Inc.25$898
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)22$785
AbbVie(2 entities)55$765
Otsuka America Pharmaceutical, Inc.29$673
Takeda Pharmaceuticals U.S.A., Inc.27$360
Lundbeck LLC15$265
Vanda Pharmaceuticals Inc.7$226
Sunovion Pharmaceuticals Inc.11$226
E.r. Squibb & Sons, L.L.C.6$197
Neurocrine Biosciences, Inc.4$175
Collegium Pharmaceutical, Inc.1$125
Eisai Inc.6$105
Tris Pharma Inc2$38
Indivior Inc.1$27
Johnson & Johnson1$14
Corium, LLC1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,114 in reported general payments places this provider in the 90th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine14$118,985
TrintellixVortioxetine Hydrobromide13$7,509
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine42$3,497
Divalproex Sodium ErDivalproex Sodium19$743
Aripiprazole17$567
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine30$561
Duloxetine Hcl24$522
Gabapentin29$450
Buspirone Hcl22$447
Sertraline Hcl18$427
Quetiapine Fumarate23$392
Clonazepam39$321
Escitalopram Oxalate21$301
Amitriptyline Hcl20$285
Lorazepam59$281

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$3,005$118,98514 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$360$7,50913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Victoria

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →